Speakers Bureau

Johnny’s Ambassadors’ Speakers

Laura Stack, Founder & CEO of Johnny’s Ambassadors


LaTisha Bader, Ph.D

  • Women and Weed: Trends for the 21st Century
    Bader outlines the rapidly changing culture of cannabis use highlighting potency and routes of administration, perception of risk, and common exchanges regarding substance use and women’s issues.

Mike Barnes


Carla J. Berg, PhD, MBA, LP

  • Cannabis Retail, Marketing, and Young Adult Perceptions and Use Behaviors
    This presentation will provide an overview of cannabis-related state laws and regulations, particularly those related to retail, and will also provide insights into state’s cannabis related social equity initiatives and hemp-derived cannabinoid regulations.

Debbie Berndt


Jame H. Berry, DO

  • Avoiding Potholes: Navigating the Cautionary Trail of Cannabis As Medicine
    As the perception of harm has decreased and the perception of therapeutic benefit has proliferated, the number of people using cannabis has increased. This increase in use has coincided with significant mental health problems such as addiction, psychosis, and suicide, especially in young people. 

Dr. Alexandra Chisholm


Crystal Collier, Ph.D


Ben Cort


Dr. Deepak D’Souza

  • Cannabis, Cannabinoids, and Mental Illness
    This talk incorporates new research findings on the potential use of cannabinoids, and synthetic cannabinoids, in an array of mental illnesses, balanced against the potential adverse effects. 

Grace Davis

  • Johnny and Me: My Recovery from Cannabis-Induced Psychosis
    Davis recognizes the importance of drug-free initiatives and accessible mental health resources for youth. When Johnny confided in her about his mental health struggles, including psychosis and suicidality, she repeatedly advocated for and supported him. Her reports requesting mental health interventions for Johnny were not ethically addressed by those who received them.

Andy Duran


Kari Eckert


Ken Finn, MD, IASIC

  • What Parents Need to Know About Medical Marijuana
    Many parents believe that marijuana is a “safe, herbal, medical, good pain reliever.” Dr. Ken Finn seeks to bust that myth in this webinar, where you’ll be provided with the correct information about medical marijuana use. 
  • The Opioid and Cannabis Connection
    Dr. Finn is a pain management physician, who will discuss why “medical” cannabis isn’t a good alternative to treat pain. This presentation will discuss the difference between FDA approved, cannabis-based medicines and “medical” dispensary cannabis, as well as the connection between youth THC use and future opioid use.
  • Adolescent Impacts of THC Use: The Brain, Body, and Behavior
    The adolescent brain, undergoing critical synaptic pruning and myelination through the mid-20s, is uniquely vulnerable to THC’s disruption of endocannabinoid signaling, with consequences that can be permanent.

Professor Daniel Freeman


Dr. Joshua Gowin


Sian Kim Harris, PhD, MSN, RN, PMHNP-BC, CPH

  • Supporting Pediatric Primary Care Providers: Screening for Cannabis Use in Adolescent Patients and Counseling Towards Behavior Change
    Evidence-based strategies for high-quality universal cannabis use screening and brief counseling for adolescents seen in pediatric primary care offices.

Keith Hayes


Yasmin Hurd PhD

  • Cannabis and the Adolescent Brain: Impact on Development, Addiction, and Epigenetic Trajectory
    This talk will provide insights about biological mechanisms underlying the developmental effects of cannabis exposure—especially THC—and examine how these changes may influence mental health risk later in life.

Dr. Jibran Khokhar


Dr. Emily Kline


Dr. Steven Laviolette


Kriya Lendzion


Roneet Lev, MD

  • Medical Marijuana Fact or Fiction
    Learn fact from fiction as Dr. Lev takes you through from glaucoma to seizures dispelling the myths of “medical” marijuana based on science and clinical experience as an emergency physician.
  • The Reality from the Emergency Room
    Is marijuana a medicine? It’s very confusing. Isn’t it safer than deadly opioids for pain? No one dies of marijuana, right? 

Mario Lintz, MD, PhD


Dr. Bertha Madras

  • Emerging Challenges for THC Policy and Prevention
    The rationale for re-scheduling marijuana, psychedelic substances, stigma and de-stigmatization, and emerging challenges to prevention.
  • Marijuana: State of the Science
    An overview of marijuana: how it acts in the brain, risk factors, brain changes, addiction, deficits-cognition, amotivation, psychiatric problems, safety issues, psychosis, schizophrenia, depression, and pain.

Jo McGuire


Dr. Erik Messamore


Melissa Moore


Roberto Olivardia, Ph.D


Robert Lee Page II, PharmD, MSPH


Michelle R. Peace, PhD

  • Up In Smoke? The Industry’s Narratives About Cannabis Quality Assurance
    The cannabis industry created and advertised a narrative for consumers about the use and safety of cannabis that have been largely accepted with limited scientific foundation. 

Matt Poling, MD


Karen Randall, MD


Nik Rao, MD, Msc

  • Cannabis Cessation Strategies and Withdrawal Management
    Both cultural perception and accelerating legalization of cannabis has led to a landscape of increasing short and long-term morbidity especially amongst teens and young adults, who are at the highest risk of cannabis-associated neuropsychiatric sequelae. 
  • Cannabis-Induced Psychosis: Psychosis and Mania
    The basics of psychosis and mania and what makes bipolar disorder, schizophrenia, and schizoaffective disorder different, and what makes them similar.

Paula Riggs, MD


Brad Roberts, MD

  • Psychosis, Suicide, Hyperemesis, and the Not-So-Medical Marijuana
    Dr. Brad Roberts is an Emergency Medicine Physician whose presentation covers recent cases from his last block of shifts (identifying features will be changed for privacy) with urine screens only positive for cannabis, including suicidality, psychosis, and vomiting.

Dr. Matthew Rossheim


Lynn Silver, MD, MPH, FAAP


Libby Stuyt, MD


Sue Thau

  • Marijuana Rescheduling: Understanding the Impacts and Implications
    An in-depth look at ongoing efforts to reschedule marijuana and the potential consequences for public health, policy, and prevention efforts. 

Dr. Christian Thurstone


Eric Voth, MD

  • Should Marijuana Be a Medical Option?
    Parents should remember that marijuana remains a Schedule I drug. It has not been approved as safe and efficacious by the Food and Drug Administration at any level for adolescents. 

Dr. Aaron Weiner


Susan Weiss


Gianna Yunker, CIP, CAI, CFRS, CRS